Some of these cancers with evidence of NF-kB activation expressed abundant RelA, which was present in both the nucleus and cytoplasm (nPcH); these cancers may possess an active NF-kB pathway stimulated by paracrine or autocrine factors. Here, NFKB1 is linked to cancer.